H.C. Wainwright upgraded Korro Bio (KRRO) to Buy from Neutral with a $20 price target The firm says KRRO-121 adds a second, “independently risk-mitigated asset as a call option.” Korro shares are trading near a zero eEnterprise value, the analyst tells investors in a research note. H.C. Wainwright believes KRRO-121 is not a read-through from KRRO-110,” so this is a truly independent shot on goal.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KRRO:
- Korro Bio upgraded to Buy from Neutral at Chardan
- Piper upgrades Korro to Overweight on bullish KRRO-121 view
- Korro Bio upgraded to Overweight from Neutral at Piper Sandler
- Midday Fly By: AT&T reports Q4 beat, Amazon cuts 16,000 jobs
- Oppenheimer upgrades Korro Bio to Outperform as KRRO-121 offers fresh story